Keyphrases
Adult Male
12%
Anti-inflammatory Potential
12%
Boswellia
12%
Boswellia Sacra
100%
Boswellic Acid
12%
Clinical Phase
12%
Controlled Clinical Trial
100%
Eco-friendly
12%
Exclusion Criteria
12%
Female Patients
12%
Frankincense
100%
Inclusion Criteria
12%
Intolerance
12%
Luban
100%
Male Patients
12%
Medicinal Uses
12%
Natural Products
37%
Non-surgical Treatment
12%
Oman
12%
Placebo
100%
Radiolucent Stones
12%
Radiopaque
12%
Randomized Placebo-controlled Trial
12%
Rat Model
12%
Renal Comorbidities
12%
Renal Cyst
12%
Renal Pathology
12%
Renal Stone
100%
Renal Tumor
12%
Resin
12%
Safe Products
12%
Safety Efficacy
12%
Scientific Community
12%
Social Use
12%
Stone Size
25%
Therapeutic Potential
12%
Treatment Development
12%
Treatment Group
12%
Treatment Strategy
12%
Treatment Toxicity
12%
Treatment Trials
12%
Young Female
12%
Pharmacology, Toxicology and Pharmaceutical Science
Anti-Inflammatory Drug
12%
Boswellia
12%
Boswellia Sacra
100%
Boswellic Acid
12%
Comorbidity
12%
Controlled Clinical Trial
100%
Frankincense
100%
Kidney Cyst
12%
Kidney Tumour
12%
Natural Product
25%
Nephrolithiasis
100%
Placebo
100%
Rat Model
12%
Side Effect
12%
Tree
25%
Uralyt U
12%
INIS
adults
9%
animals
9%
capsules
9%
clinical trials
100%
communities
9%
control
9%
cysts
9%
females
9%
host
9%
inclusions
9%
inflammation
9%
kidneys
100%
males
9%
management
9%
oman
9%
pathology
9%
patients
36%
people
9%
rats
9%
reduction
9%
resins
9%
safety
100%
side effects
9%
size
27%
surgery
9%
toxicity
9%
tumors
9%